POM-V Prescription Required

ProteqFlu-Te Suspension for Injection for Horses

Active ingredients: Clostridium tetani, Equine influenza virus

Form

Injection

Species

Horses

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

04491/5048

What it's used for

Active immunisation of horses of 4 months of age or older against equine influenza to reduce clinical signs and virus excretion after infection, and agains...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Clostridium tetani + Equine...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

ProteqFlu-Te Suspension for Injection for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Active immunisation of horses of 4 months of age or older against equine influenza to
reduce clinical signs and virus excretion after infection, and against tetanus to prevent
mortality.
Onset of immunity: 2 weeks after primary vaccination course. Duration of immunity
induced by the vaccination scheme:

Issued: April 2023
AN: 00912/2022
- 5 months after the primary vaccination course;
- after the primary vaccination course and the booster injection 5 months later: 1 year
with regard to equine influenza and 2 years with regard to tetanus.

None.

Horses:
Rare
(1 to 10 animals / 10,000 animals
treated):
Injection site swelling
, increased skin
temperature, muscle stiffness, injection
site pain

Elevated temperature
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Injection site abscess
Apathy, decreased appetite
Hypersensitivity reaction
1
transient.

usually regresses within 4 days; in rare occasions swelling can reach a
diameter up to 15–20 cm, with duration up to 2–3 weeks that may require symptomatic
treatment.
max. 1.5°C, for 1 day, exceptionally 2 days.
the day after vaccination.
which may require appropriate symptomatic treatment.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the last section of the

Issued: April 2023
AN: 00912/2022
package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for use in animals:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

Safety and efficacy data are available which demonstrate that this vaccine can be
administered on the same day but not mixed with Boehringer Ingelheim’s inactivated
vaccine against rabies.
The vaccines should be given at different sites.

Store and transport refrigerated (2 °C - 8 °C).
Do not freeze.
Protect from light.

log10 FAID50*
Clostridium tetani toxoid ........................................................................................≥ 30 IU**
* vCP content checked by global FAID50 (fluorescent assay infectious dose 50 %) and
qPCR ratio between vCP.
** antitoxic antibody titre induced after repeated vaccination in guinea pig sera according
to Ph. Eur.
Adjuvant:
Carbomer ........................................................................................................................ 4
mg.
Excipients:
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.